Lundbeck

The impact of brain disorders is escalating. It is estimated that brain disorders directly affect half the world’s population, and the effects are felt throughout society. Every day we go to work to address high unmet medical needs for people living with brain disorders. Patients who have few or no treatments available. Through cutting-edge science and strong partnerships, we develop and market some of the world’s leading treatments, expanding into neuro-specialty and neuro-rare from our strong legacy within psychiatry and neurology. Our most important contribution is easing the burden of the millions of people living with brain disorders. Whether it is migraine, depression, or other brain disorders, patients, their carers, and society as a whole depend on us. At Lundbeck, we are - Advancing brain health. Transforming lives. #AdvancingBrainHealth #FocusedInnovator

We were deeply inspired by the meaningful conversations and engagements with various #migraine community leaders and healthcare providers at #AHSAZ. United by a shared vision, we are focused on elevating the standard of migraine care and advancing the treatment paradigm. Together, we will continue our efforts with passion and purpose to help transform the lives of those affected by migraine disease. #AdvancingBrainHealth #FocusedInnovator

In honor of #NationalFamilyCaregiversMonth, Lundbeck US teamed up with the Caregiver Action Network to raise awareness of the caregiver journey through a satellite media tour. Watch as Judy Krieg, Neuroscience Account Manager, shares her emotional experience being a caregiver to her mother with Alzheimer’s dementia and the important lessons she learned: https://bit.ly/3CAbWV9. #AdvancingBrainHealth #FocusedInnovator

Team Lundbeck joined the #migraine community to step out and stand up against stigma at Miles for Migraine #AHSAZ. It was a proud moment as our colleagues independently earned us the top fundraising team award to support those making an impact to improve migraine care. #migraineawareness

Every day, we work to address high unmet medical needs for people living with brain disorders, especially those with few or no treatments available. Through cutting-edge science and strong partnerships, we develop and market some of the world’s leading treatments. Expanding into neuro-specialty and neuro-rare areas builds on our strong legacy within psychiatry and neurology. At Lundbeck, 8 of our 9 development pipeline programs are focused on neuro-rare and neuro-specialty areas. Over the last five years, the share of these programs in our pipeline has increased from 40% to nearly 90%. #FocusedInnovator #BrainHealth #NeuroSpecialty #NeuroRare

We’ve just released our latest quarterly results and are proud to report a strong performance throughout the first nine months of 2024. In the third quarter, this momentum was further strengthened by the accelerating growth of our strategic brands, reflecting strong revenue growth across all strategic brands. We are also excited about the expected acquisition of Longboard Pharmaceuticals. This will complement the promising developments in our internal pipeline and enable us to take decisive steps towards establishing the neuro-rare franchise, a cornerstone in realizing our Focused Innovator strategy. Thank you to our employees and partners across the globe for your contributions to easing the burden of the millions of people living with brain disorders. For more details, check out our nine months 2024 financial highlights in the infographic below 👇 #FinancialResults #FocusedInnovator

The impact of brain disorders is escalating. Migraine is just one of these brain disorders, and it is the third-most common disease globally, impacting 1.3 billion people. At Lundbeck, our most important contribution is easing the burden of the millions of people living with brain disorders. Whether it is migraine or other brain disorders, patients, their carers, and society as a whole depend on us. (Source: The Journal of Headache and Pain (2013)) #AdvancingBrainHealth #Migraine #DiseaseAwareness

Thank you for stopping by our Valby site Morten Bødskov   It was an honor to welcome the Minister for Business and Industry, Morten Bødskov to Lundbeck yesterday.   Following the recent launch of Denmark’s new ambitious Life Science Strategy, it was a privilege to offer first-hand insight into our facilities where the majority is working within research and production. The minister had the opportunity to experience our facilities up close and meet some of our dedicated colleagues. We were also able to engage in fruitful discussions about the framework conditions that are so important for our industry to continue to thrive. We share the minister’s commitment to enhancing the value of life science for patients, their relatives and for society at large.   Many thanks to everyone who participated in this meaningful exchange. Together, we can continue to drive innovation to advance brain health and transform lives! 🧠   #Lundbeck #LifeScience #MinistryofIndustry #Advancingbrainhealth Ministry of Industry, Business and Financial Affairs

We're thrilled to be sponsoring a conversation on "Advancing Severe Migraine Care" next week in partnership with leaders in the migraine community. Register below. Date: November 4   Time: 12 – 12:30 p.m. CT  

2.8 billion people live with a neurological disorder globally – a number that is expected to grow with an aging population. At Lundbeck, we are dedicated to addressing this immense challenge. Every day we go to work to address high unmet medical needs for people living with brain disorders. Patients who have few or no treatments available. Through cutting edge science and strong partnerships, we develop and market some of the world’s leading treatments, expanding into neuro-specialty and neuro-rare from our strong legacy within psychiatry and neurology. (Source: IHME, Brain Health Atlas) #AdvancingBrainHealth #DiseaseAwareness